Back
NRX Pharmaceuticals Stock Price Chart
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
NRXP
NRX Pharmaceuticals
Last Price:
$2.86
Seasonality Move:
-22.82%
7 Day Trial
ALL ACCESS PASS
$
7
Attention Investors: The 10 Best stocks for 2025 - yours FREE
Get Your Copy of "10 Best Stocks to Own in 2025" Here.-
The current trend is moderately bearish and NRXP is experiencing selling pressure, which indicates risk of future bearish movement.
NRX Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.96 | Sell |
| 20-day SMA: | 3.09 | Sell |
| 50-day SMA: | 2.62 | Buy |
| 200-day SMA: | 2.25 | Buy |
| 8-day EMA: | 2.95 | Sell |
| 20-day EMA: | 3.03 | Sell |
| 50-day EMA: | 2.73 | Buy |
| 200-day EMA: | 2.62 | Buy |
NRX Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.49 | Sell |
| Chaikin Money Flow: | -201330 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.7 - 4.14) | Sell |
| Bollinger Bands (100): | (0.95 - 3.03) | Buy |
NRX Pharmaceuticals Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NRX Pharmaceuticals Stock
Is NRX Pharmaceuticals Stock a Buy?
-
NRX Pharmaceuticals share price is 2.85 while NRXP 8-day simple moving average is 2.96, which is a Sell signal.
-
The stock price of NRXP is 2.85 while NRX Pharmaceuticals 20-day SMA is 3.09, which makes it a Sell.
-
NRX Pharmaceuticals 50-day simple moving average is 2.62 while NRXP share price is 2.85, making it a Buy technically.
-
NRXP stock price is 2.85 and NRX Pharmaceuticals 200-day simple moving average is 2.25, creating a Buy signal.
NRXP Technical Analysis vs Fundamental Analysis
Sell
27
NRX Pharmaceuticals (NRXP)
is a Sell
Is NRX Pharmaceuticals a Buy or a Sell?
-
NRX Pharmaceuticals stock is rated a SellThe current NRX Pharmaceuticals [NRXP] share price is $2.85. The Score for NRXP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
NRX Pharmaceuticals Stock Info
Market Cap:
34.5M
Price in USD:
2.85
Share Volume:
264.9K
NRX Pharmaceuticals 52-Week Range
52-Week High:
7.33
52-Week Low:
1.10
Sell
27
NRX Pharmaceuticals (NRXP)
is a Sell
NRX Pharmaceuticals Share Price Forecast
-
What is the NRX Pharmaceuticals stock price today?The NRX Pharmaceuticals stock price is 2.85 USD today.
-
Will NRXP stock go up or go down?NRX Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NRX Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NRX Pharmaceuticals is overvalued.
Is NRX Pharmaceuticals Stock a Buy?
-
NRX Pharmaceuticals share price is 2.85 while NRXP 8-day exponential moving average is 2.95, which is a Sell signal.
-
The stock price of NRXP is 2.85 while NRX Pharmaceuticals 20-day EMA is 3.03, which makes it a Sell.
-
NRX Pharmaceuticals 50-day exponential moving average is 2.73 while NRXP share price is 2.85, making it a Buy technically.
-
NRXP stock price is 2.85 and NRX Pharmaceuticals 200-day simple moving average is 2.62, creating a Buy signal.
Fundamental Analysis of NRX Pharmaceuticals
Is NRX Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.72 per share, and a decrease next year of $0.00 per share.
Technical Analysis of NRX Pharmaceuticals
Should I short NRX Pharmaceuticals stock?
-
NRXP Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting NRX Pharmaceuticals is a Sell
-
NRX Pharmaceuticals Relative Strength Index (RSI) is 47.49, which suggest NRX Pharmaceuticals is oversold
-
The Bollinger Bands (25) for NRX Pharmaceuticals is (2.7 - 4.14), which suggest NRX Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for NRX Pharmaceuticals is (0.95 - 3.03), which suggest NRX Pharmaceuticals is a Buy
* NRX Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.